DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo-Reference-Cited by-同舟云学术

DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo

Published:2010-12-08 Issue:3 Volume:69 Page:540-552
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Wallace Lindsay M.,Garwick Sara E.,Mei Wenyan,Belayew Alexandra,Coppee Frederique,Ladner Katherine J.,Guttridge Denis,Yang Jing,Harper Scott Q.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.22275/fullpdf

Reference62 articles.

1. Prevalence of rare diseases: bibliographic data http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf 2010

2. Severe phenotype in infantile facioscapulohumeral muscular dystrophy;Klinge;Neuromuscul Disord,2006

3. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandem repeated unit;van Deutekom;Hum Mol Genet,1993

4. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy;Wijmenga;Nat Genet,1992

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D4Z4 Hypomethylation in Human Germ Cells;Cells;2024-09-06

2. Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape;International Journal of Molecular Sciences;2024-08-21

3. The emerging roles of necroptosis in skeletal muscle health and disease;Pflügers Archiv - European Journal of Physiology;2024-07-22

4. SMCHD1 activates the expression of genes required for the expansion of human myoblasts;Nucleic Acids Research;2024-07-12

5. Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD;International Journal of Molecular Sciences;2024-06-26